stemmacolore
Cerca

A randomised phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumour (GIST)

A randomised phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumour (GIST)

A randomised phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumour (GIST)

Stato
Attivo - reclutamento chiuso
Codice studio
EORTC 1321
Codice EudraCT
2015-001298-42
Sponsor/Promotore
EORTC
Tipologia
Sperimentale
Fase
II
Unità Operativa
Principal Investigator
Torna in alto